Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash from Financing Activities (2016 - 2025)

Xtant Medical Holdings has reported Cash from Financing Activities over the past 16 years, most recently at -$5.8 million for Q3 2025.

  • Quarterly Cash from Financing Activities fell 208.6% to -$5.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$6.9 million through Sep 2025, down 139.89% year-over-year, with the annual reading at $16.1 million for FY2024, 18.37% down from the prior year.
  • Cash from Financing Activities was -$5.8 million for Q3 2025 at Xtant Medical Holdings, down from $662000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $18.1 million in Q1 2021 and troughed at -$5.8 million in Q3 2025.
  • The 5-year median for Cash from Financing Activities is $662000.0 (2025), against an average of $3.0 million.
  • The largest YoY upside for Cash from Financing Activities was 53311.76% in 2021 against a maximum downside of 1515.0% in 2021.
  • A 5-year view of Cash from Financing Activities shows it stood at -$55000.0 in 2021, then skyrocketed by 10307.27% to $5.6 million in 2022, then crashed by 94.21% to $325000.0 in 2023, then tumbled by 362.77% to -$854000.0 in 2024, then crashed by 575.76% to -$5.8 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Cash from Financing Activities are -$5.8 million (Q3 2025), $662000.0 (Q2 2025), and -$919000.0 (Q1 2025).